1. Home
  2. USNA vs FHTX Comparison

USNA vs FHTX Comparison

Compare USNA & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

HOLD

Current Price

$22.08

Market Cap

397.1M

Sector

Health Care

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$5.87

Market Cap

323.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
FHTX
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.1M
323.4M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
USNA
FHTX
Price
$22.08
$5.87
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$11.50
AVG Volume (30 Days)
107.6K
366.7K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.32
EPS
0.41
N/A
Revenue
$1,060,902,000.00
$30,909,000.00
Revenue This Year
$3.90
$8.89
Revenue Next Year
$6.21
$20.13
P/E Ratio
$53.73
N/A
Revenue Growth
N/A
36.75
52 Week Low
$16.60
$3.27
52 Week High
$38.32
$6.95

Technical Indicators

Market Signals
Indicator
USNA
FHTX
Relative Strength Index (RSI) 64.38 68.76
Support Level $18.71 $4.37
Resistance Level $22.71 $6.95
Average True Range (ATR) 0.86 0.43
MACD 0.15 0.18
Stochastic Oscillator 88.77 70.22

Price Performance

Historical Comparison
USNA
FHTX

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Share on Social Networks: